Pregnancy and Birth

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

Questions this month have been answered by:Harvey S. Marchbein, MD, FACOG, FACS, OBGYN.net Osteoporosis Chairman and Editorial Advisor Paul D. Burstein, MD, FACOG, OBGYN.net Osteoporosis Editorial Advisor

Q: Is the treatment for Osteoporosis different for males than females? I am a 67 year old male. Recently by x-rays of my back, it was stated in the report that I have osteoporosis . In a phone conversation with my primary physician's assistant, he stated that I should be on hormones, but that he would have to run it by the primary physician. Since that time, and this was at thanksgiving, I have tried to make contact, by phone to the primary physician. I was told, by office personnel, that I should make an appointment to discuss the situation. My question is, why is it necessary to discuss treatment face to face? Can't he advise me by phone? What is necessary? My schedule is very irregular and also why the extra expense for an office visit just to say here is what you do and if a prescription is necessary, can't he call it in as has been done on other occasions. I would like to know also, isn't it rather uncommon for a male to have this condition? Could you tell me what is the usual treatment in this kind of situation?

In infertile women undergoing therapy with assisted reproductive techniques, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), the use of gonadotropins to achieve multifollicular development is now well established.

ICSI (intracytoplasmic sperm injection) is arguably the biggest advance in assisted reproductive technology since the successful birth of Louise Brown, 21 years ago.

It is apparent that male infertility is associated with mild to moderate expansion of the CAG trinucleotide repeat in the transactivation domain of the androgen receptor gene.

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

OBGYN.net Conference CoverageFrom the 11th World Congress on Human Reproduction, June 2002

OBGYN.net Conference CoverageFrom the ESHRE 2001 Conference - Lausanne, Switzerland

Implantation is a complicated process that involves adequate preparation of the endometrium.

When a blastocyst expands with the growth of the blastocoel, it stretches and thins the zona pellucida (ZP), ultimately rupturing the ZP allowing the embryo to hatch free ready for implantation.

The routine transfer of cleavage stage embryos to the patient’s uterus on day 2 or 3 has two inherent drawbacks; firstly the embryo does not reside in the uterus at such time, and secondly, up to the 8-cell stage one is observing a cleaving oocyte, in that the majority of embryonic genes have not been activated.

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999

The First World Congress On: Controversies in Obstetrics, Gynecology & InfertilityPrague, Czech Republic - 1999